Cassella James V 4
4 · Trevi Therapeutics, Inc. · Filed Oct 1, 2024
Insider Transaction Report
Form 4
Cassella James V
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2024-09-30+400,000→ 400,000 totalExercise: $3.34Exp: 2034-09-29→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]This option was granted on September 30, 2024. The 400,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on September 30, 2025 and as to the remaining 75% of the shares in equal monthly installments thereafter, through September 30, 2028.